Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroperitoneal fibrosis: evolving concepts.

Augusto Vaglio1, Alessandra Palmisano, Domenico Corradi

  • 1Dipartimento di Clinica Medica, Nefrologia e Scienze della Prevenzione, Università degli Studi di Parma, Via Gramsci 14, 43100 Parma, Italy. augusto.vaglio@virgilio.it

Rheumatic Diseases Clinics of North America
|November 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis.

EULAR rheumatology open·2026
Same author

Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levels.

British journal of haematology·2026
Same author

Eculizumab for rapidly progressive glomerulonephritis in children.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Xanthogranulomatous Inflammatory Pelvic Mass Mimicking Malignancy: Successful Conservative Treatment and Narrative Insights into Diagnosis and Management.

Journal of clinical medicine·2026
Same author

A trial of hypoimmune allogeneic CD19-targeting T cells in refractory systemic lupus erythematosus.

Clinical kidney journal·2026
Same author

Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey.

Rheumatology (Oxford, England)·2026
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Retroperitoneal fibrosis (RPF) is a rare inflammatory condition, often idiopathic. While its exact cause is unknown, autoimmune factors are suspected, and treatment typically involves immunosuppressants.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Retroperitoneal fibrosis (RPF) is a rare fibro-inflammatory condition.
  • Most cases are idiopathic, but secondary causes exist.
  • The pathogenesis of idiopathic RPF is poorly understood, with suspected immunogenetic and autoimmune involvement.

Purpose of the Study:

  • To describe the characteristics of retroperitoneal fibrosis.
  • To explore potential immunopathologic mechanisms.
  • To outline current treatment strategies and disease course.

Main Methods:

  • Literature review of idiopathic and secondary RPF.
  • Analysis of clinical presentation and associations.
  • Evaluation of treatment efficacy and disease relapses.

Related Experiment Videos

Main Results:

  • Idiopathic RPF typically affects the abdominal aorta and iliac arteries, sometimes mimicking large-vessel vasculitis.
  • The condition is frequently associated with other autoimmune diseases.
  • Glucocorticoids and immunosuppressants are common treatments, but RPF often follows a relapsing course.

Conclusions:

  • RPF is a complex inflammatory condition with likely autoimmune underpinnings.
  • Effective management requires addressing potential autoimmune triggers and managing the chronic, relapsing nature of the disease.